Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mónica Carbajales-Álvarez"'
Autor:
Lola Macía Rivas, Mónica Carbajales-Álvarez, Clara Fernández-Laguna, Cristina Álvarez-Asteinza, Iván Maray-Mateos, Ana Lozano-Blázquez
Aim Assess the effectiveness and safety of nivolumab versus cetuximab in patients with R/M HNSCC, as well as to analyze possible prognostic factors for response to treatment with nivolumab. Methods We conducted an observational, retrospective, descri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b0692e1d8818cb9df7ff3b1ef2bee38
https://doi.org/10.22541/au.166124890.02774033/v1
https://doi.org/10.22541/au.166124890.02774033/v1
Autor:
Iván, Maray-Mateos, Cristina, Álvarez-Asteinza, Mónica, Carbajales-Álvarez, Ana, Lozano-Blázquez
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 45(6)
Autor:
Ana Lozano-Blázquez, Fernando Martínez-Martínez, Mónica Carbajales-Álvarez, Patricio Suárez-Gil, Miguel Ángel Calleja-Hernández, Cecilia Calvo-Pita
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Therapeutics and Clinical Risk Management
instname
Therapeutics and Clinical Risk Management
Ana Lozano-Blázquez,1 Cecilia Calvo-Pita,2 Mónica Carbajales-Álvarez,1 Patricio Suárez-Gil,3 Fernando Martínez-Martínez,4 Miguel Ángel Calleja-Hernández51Pharmacy Department, Hospital de Cabueñes, Gijón, Spain; 2Pharmacy Department, Primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb6023ae40757e16d90288596ae66ba7
http://hdl.handle.net/10481/33085
http://hdl.handle.net/10481/33085